Patents by Inventor John Lacey

John Lacey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240325341
    Abstract: of treating Gram-negative bacteria that also exhibit resistance to the anti-bacterial compound colistin (MIC?50 mg/mL) except for Burkholderia, Proteus, and Serratia that comprises contacting the bacteria with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, below, dissolved or dispersed therein at a concentration of about 0.01 to about 15 mg/mL and irradiating those contacted bacteria with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 16 to about 160 J/cm2, treat and kill the irradiated bacteria wherein X, R1, R2 and M+ are defined within.
    Type: Application
    Filed: March 25, 2024
    Publication date: October 3, 2024
    Applicants: Provectus Pharmatech, Inc., University of Tennessee Research Foundation
    Inventors: Michio KUROSU, Dominic Rodrigues, Edward V. Pershing, Bruce Horowitz, John Lacey, Eric A. Wachter
  • Publication number: 20230233515
    Abstract: This invention contemplates combined use of a rose bengal (RB) derivative with irradiation of bacteria with light to treat and kill the irradiated bacteria. In one aspect, Gram-positive bacteria are treated in a method in which the bacteria are contacted with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, discussed within, dissolved or dispersed therein at about 0.2 to about 3.1 µg/mL. Those contacted bacteria are contacted with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 0.7 to about 7.2 J/cm2. A similar method is contemplated for treating Gram-negative bacteria that are one or more of Burkholderia, Salmonella, and Proteus using an aqueous pharmaceutical composition containing about 2 to about 15 µM concentration of the RB compound.
    Type: Application
    Filed: December 27, 2022
    Publication date: July 27, 2023
    Applicants: Provectus Pharmatech, Inc., University of Tennessee Research Foundation
    Inventors: Michio KUROSU, Dominic RODRIGUES, Edward V. PERSHING, Bruce HOROWITZ, John LACEY, Eric A. WACHTER
  • Patent number: 5774914
    Abstract: A hospital bed (10) especially adapted for use by a woman giving birth is disclosed. The bed includes a base (11) on which a litter frame (12) is positioned. A lift assembly (14) attached to the base and is connected to a inner frame (50) located inside the litter frame. The lift assembly moves the inner frame and litter frame up and down. The litter frame is pivotally connected to the inner frame so that the litter frame can be selectively moved in the Trendelenburg position. A Fowler frame (16) is attached to the litter frame so that it can be both pivoted upwardly from the horizontal and selectively moved toward the seat end of the litter frame. Foot rests (30) are attached to the under surface of the litter frame and can be swung into position as needed. Leg rests (34) are mounted to the under surface of the foot rests and likewise be simply pivoted in place. A foot frame (24) is attached to the seat end of the litter frame and can be readily separated from the rest of the bed.
    Type: Grant
    Filed: January 5, 1996
    Date of Patent: July 7, 1998
    Assignee: Stryker Corporation
    Inventors: Ned Johnson, John Luecke, John Lacey